Catalyst Capital Advisors LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 34 filers reported holding SUTRO BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Catalyst Capital Advisors LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q1 2019$6,000
+20.0%
5000.0%0.00%
Q4 2018$5,000
-37.5%
5000.0%0.00%
Q3 2018$8,0005000.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$13,773,0003.47%
AJU IB Investment Co., Ltd. 175,000$1,439,0002.22%
Frazier Life Sciences Management, L.P. 1,776,479$14,603,0001.24%
First Light Asset Management, LLC 1,672,497$13,748,0001.21%
BVF INC/IL 3,447,946$28,342,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,732,400$30,680,0000.94%
Endurant Capital Management LP 296,508$2,437,0000.64%
Parkman Healthcare Partners LLC 199,846$1,643,0000.48%
Eventide Asset Management 2,708,975$22,268,0000.35%
Lombard Odier Asset Management (Switzerland) SA 391,024$3,214,0000.25%
View complete list of SUTRO BIOPHARMA INC shareholders